Please login to the form below

Not currently logged in
Email:
Password:

Merck Serono to invest €150m in China R&D

Merck Serono has announced plans to invest more than €150m and create over 200 jobs through establishing a global R&D centre in Beijing, China

Merck Serono has revealed plans to invest more than €150m and create over 200 qualified jobs over the next four years through establishing a global research and development centre in Beijing, China. Merck Serono China currently has over 1,000 employees nationwide.

The company expects the China R&D organisation to sit alongside its hubs in Germany, Switzerland and the US as key worldwide R&D hubs for Merck Serono.

"The creation of the China R&D centre marks a new milestone in Merck Serono's commitment to China, where there is a rising demand for more healthcare options," said Elmar Schnee, president of Merck Serono.

Drug development for China and other Asian countries, including local clinical trials and participation in global trials, will be led by the China team. The team will seek out partnerships with local companies and academic institutions, and ensure collaborations with research institutions in China are managed effectively.

Pharmacogenomics, bioanalytics and other biomarker research will be the key focus of the Beijing R&D centre.

The Swiss-based company's key products  Erbitux (cancer), Rebif (multiple sclerosis), Gobal-f (infertility), Saizen (endocrine and metabolic disorders) and Concor and Euthyrox (cardiometabolic diseases) are already available in the country through Merck Serono China.

23rd November 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...